WuXi AppTec won a preliminary injunction in the 1260H case after a judge ruled that the U.S. Department of Defense’s designation of the company as a “Chinese military company” was likely arbitrary and capricious. The ruling offers near-term legal protection while the matter continues through the courts. The dispute is tied to how government entities assess and apply designations that can affect procurement, partnerships, and compliance obligations for affected firms. A preliminary injunction does not resolve the underlying determination, but it can materially change practical business constraints during ongoing litigation. For biotech services providers, the case is a reminder that geopolitical review processes can quickly become operational risk factors, even for companies whose core businesses are drug development and manufacturing support.